Clinical Trials at University of Oklahoma
As of August 2026, 27 paid clinical trials are recruiting at University of Oklahoma, located at 1201 N STONEWALL AVE, OKLAHOMA CITY, OK 73117-1214, phone (405) 271-5714 in Oklahoma City, Oklahoma. Active studies at this site cover conditions such as Endometrial Cancer, Ovarian Cancer and Acute Myeloid Leukemia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Oklahoma City
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
28 clinical trials at University of Oklahoma
·Clear filters·BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
A Study of NX-1607 in Adults With Advanced Malignancies
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Limited Versus Extended Trophic Feeding (LET-FEED) Trial
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone
Stroke Thrombectomy and Aneurysm Registry
Digital Chest Tube Drainage System (Thopaz+) Versus Analog in Pediatric Patients
Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
ctDNA Assay in Patients With Resectable Pancreatic Cancer
Uterine Preservation Via Lifestyle Transformation
Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow
tDCS for Post-Stroke Cognitive Impairment
Outcomes in Simulated Endoscopy Training
Common conditions studied in Oklahoma City
- Endometrial Cancer (17 active studies)
- Ovarian Cancer (14 active studies)
- Acute Myeloid Leukemia (13 active studies)
- Malignant Solid Neoplasm (10 active studies)
- Breast Cancer (9 active studies)
- Major Depressive Disorder (9 active studies)
Leading research sponsors in Oklahoma City
- University of Oklahoma
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- SWOG Cancer Research Network
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Oklahoma City?
There are approximately 595 recruiting clinical trials in Oklahoma City, Oklahoma listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Oklahoma City pay participants?
Most recruiting trials in Oklahoma City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Oklahoma City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Oklahoma City?
The most common conditions under active study in Oklahoma City include Endometrial Cancer (17), Ovarian Cancer (14), Acute Myeloid Leukemia (13), Malignant Solid Neoplasm (10), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Oklahoma City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Oklahoma City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Oklahoma City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Oklahoma City?
Recruiting research sites in Oklahoma City include University of Oklahoma Health Sciences Center, Mercy Hospital Oklahoma City, University of Oklahoma, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Oklahoma City right now?
The largest active categories in Oklahoma City are Cancer & tumors (249), Cardiovascular (40), Diabetes & metabolic (27). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of University of Oklahoma?
University of Oklahoma is located at 1201 N STONEWALL AVE, OKLAHOMA CITY, OK 73117-1214. Use the Google Maps link in the intro above to get directions.
How do I contact University of Oklahoma?
You can reach University of Oklahoma by phone at (405) 271-5714. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.